Search for: "Shionogi "
Results 21 - 40
of 41
Sorted by Relevance
|
Sort by Date
17 Oct 2017, 6:09 pm
He noted that the recent litigation between Shionogi v Merck (in which the German Federal Court of Justice confirmed the decision of the Federal Patent Court granting Merck a compulsory license to EP 1 422 218 owned by Shionogi) demonstrated the circumstances where the public interest would support the grant of a compulsory license. [read post]
16 Apr 2011, 11:53 am
Here are the latest featured in-house counsel jobs, courtesy of GoInhouse.com: Litigation Counsel – Confidential, Houston, TX Corporate Counsel – Litigation – Pfizer, New York, NY Assistant General Counsel – Intellectual Property – Honeywell, Danbury, CT Attorney – SEC/Corporate – The Home Depot, Atlanta, GA Senior Counsel – Bank Regulatory – BarkerGilmore, Buffalo, NY Medical Device Counsel – BarkerGilmore, Seattle, WA FDA Regulatory,… [read post]
3 Aug 2010, 10:00 am
Cuvposa (glycopyrrolate) Oral Solution is marketed by Shionogi Pharma Inc. of Osaka, Japan. [read post]
5 Oct 2011, 5:33 pm
In addition, the generics allege that original patent applicant, Shionogi (from whom AstraZeneca licenses the Crestor patent), withheld crucial documents from the USPTO in the patent application process. [read post]
9 Mar 2017, 4:41 pm
The patent proprietor, Japanese pharmaceutical company Shionogi, sued Merck in 2015 for patent infringement before the Landgericht Duesseldorf (District Court) and requested an injunction (LG Düsseldorf 4c O 48/15) after the license negotiations between the parties had failed. [read post]
7 Feb 2012, 8:52 am
Cir. 2012) In a December 2011 order, the Delaware district court awarded preliminary injunctive relief to Sciele and Shionogi and forcing Lupin to stop selling generic versions of the patentee's diabetes drug Fortamet (metformin). [read post]
16 Dec 2016, 4:44 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off… [read post]
6 Jan 2017, 2:01 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off… [read post]
22 Dec 2016, 8:35 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off… [read post]
30 Dec 2016, 2:58 pm
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off… [read post]
5 May 2010, 4:46 am
(Patent Docs) Fenoglide (Fenofibrate)– US:Patent infringement complaint filed in response to Para IV certification: Shionogi Pharma Inc. et al. v. [read post]
22 Dec 2010, 3:01 am
(Patent Docs) Lovenox (Enoxaparin) – US: Sanofi seeks summary judgment in generic Lovenox dispute; administrative record highlights disagreements at FDA over generic approval (FDA Law Blog) Orapred ODT (Prednisolone) – US: Patent infringement complaint filed following a Paragraph IV certification: Shionogi Pharma Inc. et al. v. [read post]
27 Jul 2011, 1:01 am
(IPBiz) (Patently-O) (Patent Docs) (GenericsWeb) Copaxone (Glatiramer) – US: Mylan and Momenta challenge Teva patent on Copaxone (IPBiz) Gemzar (Gemcitabine) – US: Strides Arcolab announces US FDA approval for Gemcitabine for injections USP (GenericsWeb) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Jalyn (Dutasteride, Tamsulosin) – US: Watson files ANDA to market generic Jalyn, Glaxo responds… [read post]
7 Jun 2010, 9:36 am
Susumu Makino at Shionogi Research Laboratories or has been reproductively separated from that colony by 20 or fewer generations. [read post]
20 Dec 2012, 12:20 pm
Here, the district court found as fact that Shionogi erred by failing to file an IDS citing the Sandoz and Bayer references, and by omitting a specific claim to the preferred species. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
8 Feb 2021, 9:16 am
Readers of the Blog should remember the French landmark French judgment rendered in September 2020 in the European Pemetrexed saga, which condemned Fresenius to pay € 28 million in damages (see here). [read post]
25 Jan 2017, 10:48 pm
Like AIPPI's final talk of 2016, the AmeriKat is alsobristling - but instead of patent law issues, she is bristling having spotted someone wearing socks with sandalsRight before the Christmas holidays, the UK Group of AIPPI held the annual session devoted to reviewing the year's patent cases. [read post]
6 Apr 2023, 6:38 am
The judge reviewed the national case law on selections/deletions from multiple lists (Merck v Shionogi [2016] EWHC 2989 (Pat), Nokia v IPCom [2012] EWCA Civ 567 and GlaxoSmithKline v Wyeth [2016] EWHC 1045 (Pat)) and the EPO cases reviewed therein and in the EPO Case Law Book. [read post]
